Gibbons A - Search Results

1

Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA.

Scarr E, Craig JM, Cairns MJ, Seo MS, Galati JC, Beveridge NJ, Gibbons A, Juzva S, Weinrich B, Parkinson-Bates M, Carroll AP, Saffery R, Dean B. Scarr E, et al. Among authors: gibbons a. Transl Psychiatry. 2013 Feb 19;3(2):e230. doi: 10.1038/tp.2013.3. Transl Psychiatry. 2013. PMID: 23423139 Free PMC article.

2

Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects.

Gibbons AS, Scarr E, McLean C, Sundram S, Dean B. Gibbons AS, et al. J Affect Disord. 2009 Aug;116(3):184-91. doi: 10.1016/j.jad.2008.11.015. Epub 2008 Dec 21. J Affect Disord. 2009. PMID: 19103464 Free PMC article.

3

Regional and duration of illness differences in the alteration of NCAM-180 mRNA expression within the cortex of subjects with schizophrenia.

Gibbons AS, Thomas EA, Dean B. Gibbons AS, et al. Schizophr Res. 2009 Jul;112(1-3):65-71. doi: 10.1016/j.schres.2009.04.002. Epub 2009 May 2. Schizophr Res. 2009. PMID: 19411161 Free PMC article.

4

Regionally-specific changes in levels of tumour necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorder.

Dean B, Tawadros N, Scarr E, Gibbons AS. Dean B, et al. J Affect Disord. 2010 Jan;120(1-3):245-8. doi: 10.1016/j.jad.2009.04.027. J Affect Disord. 2010. PMID: 19446343

5

Recent advances in postmortem pathology and neurochemistry in schizophrenia.

Dean B, Boer S, Gibbons A, Money T, Scarr E. Dean B, et al. Among authors: gibbons a. Curr Opin Psychiatry. 2009 Mar;22(2):154-60. doi: 10.1097/YCO.0b013e328323d52e. Curr Opin Psychiatry. 2009. PMID: 19553869 Review.

6

Treating schizophrenia: novel targets for the cholinergic system.

Money TT, Scarr E, Udawela M, Gibbons AS, Jeon WJ, Seo MS, Dean B. Money TT, et al. Among authors: gibbons as. CNS Neurol Disord Drug Targets. 2010 Apr;9(2):241-56. doi: 10.2174/187152710791012062. CNS Neurol Disord Drug Targets. 2010. PMID: 20053170 Review.

7

The neurobiology of APOE in schizophrenia and mood disorders.

Gibbons AS, Udawela M, Jeon WJ, Seo MS, Brooks L, Dean B. Gibbons AS, et al. Front Biosci (Landmark Ed). 2011 Jan 1;16(3):962-79. doi: 10.2741/3729. Front Biosci (Landmark Ed). 2011. PMID: 21196212 Free article. Review.

8

Low Density Lipoprotein Receptor-Related Protein and Apolipoprotein E Expression is Altered in Schizophrenia.

Gibbons AS, Thomas EA, Scarr E, Dean B. Gibbons AS, et al. Front Psychiatry. 2010 Jul 8;1:19. doi: 10.3389/fpsyt.2010.00019. eCollection 2010. Front Psychiatry. 2010. PMID: 21423430 Free PMC article.

9

AMPA receptor expression is increased post-mortem samples of the anterior cingulate from subjects with major depressive disorder.

Gibbons AS, Brooks L, Scarr E, Dean B. Gibbons AS, et al. J Affect Disord. 2012 Feb;136(3):1232-7. doi: 10.1016/j.jad.2011.10.001. Epub 2011 Oct 28. J Affect Disord. 2012. PMID: 22036795 Free PMC article.

10

Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia.

Gibbons AS, Scarr E, Boer S, Money T, Jeon WJ, Felder C, Dean B. Gibbons AS, et al. Int J Neuropsychopharmacol. 2013 Feb;16(1):37-46. doi: 10.1017/S1461145712000028. Epub 2012 Feb 17. Int J Neuropsychopharmacol. 2013. PMID: 22338582 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

770 results

Search Page